Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis.

Koskinen J, Löhönen J, Koponen H, Isohanni M, Miettunen J.

Schizophr Bull. 2010 Nov;36(6):1115-30. doi: 10.1093/schbul/sbp031. Epub 2009 Apr 22.

PMID:
19386576
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

[Cannabis and schizophrenia: demographic and clinical correlates].

Dervaux A, Laqueille X, Bourdel MC, Leborgne MH, Olié JP, Lôo H, Krebs MO.

Encephale. 2003 Jan-Feb;29(1):11-7. French.

PMID:
12640322
[PubMed - indexed for MEDLINE]
3.

Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addiction.

Dubertret C, Bidard I, Adès J, Gorwood P.

Schizophr Res. 2006 Sep;86(1-3):284-90. Epub 2006 Jun 27.

PMID:
16806837
[PubMed - indexed for MEDLINE]
4.

Prevalence of alcohol use disorders in schizophrenia--a systematic review and meta-analysis.

Koskinen J, Löhönen J, Koponen H, Isohanni M, Miettunen J.

Acta Psychiatr Scand. 2009 Aug;120(2):85-96. doi: 10.1111/j.1600-0447.2009.01385.x. Epub 2009 Apr 3. Review.

PMID:
19374633
[PubMed - indexed for MEDLINE]
5.

Craving in patients with schizophrenia and cannabis use disorders.

Schnell T, Becker T, Thiel MC, Gouzoulis-Mayfrank E.

Can J Psychiatry. 2013 Nov;58(11):646-9.

PMID:
24246436
[PubMed - indexed for MEDLINE]
6.

Cannabis use and cannabis use disorders among individuals with mental illness.

Lev-Ran S, Le Foll B, McKenzie K, George TP, Rehm J.

Compr Psychiatry. 2013 Aug;54(6):589-98. doi: 10.1016/j.comppsych.2012.12.021. Epub 2013 Jan 31.

PMID:
23375264
[PubMed - indexed for MEDLINE]
7.

[Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].

Liraud F, Verdoux H.

Encephale. 2002 Mar-Apr;28(2):160-8. French.

PMID:
11972143
[PubMed - indexed for MEDLINE]
8.

Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective.

Hambrecht M, Häfner H.

Aust N Z J Psychiatry. 2000 Jun;34(3):468-75.

PMID:
10881971
[PubMed - indexed for MEDLINE]
9.

Elevated rates of substance use disorders in non-psychotic siblings of individuals with schizophrenia.

Smith MJ, Barch DM, Wolf TJ, Mamah D, Csernansky JG.

Schizophr Res. 2008 Dec;106(2-3):294-9. doi: 10.1016/j.schres.2008.07.015. Epub 2008 Sep 5.

PMID:
18774264
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

[Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].

Guillem E, Pelissolo A, Vorspan F, Bouchez-Arbabzadeh S, Lépine JP.

Encephale. 2009 Jun;35(3):226-33. doi: 10.1016/j.encep.2008.03.010. Epub 2008 Aug 19. French.

PMID:
19540408
[PubMed - indexed for MEDLINE]
11.

Cannabis use and age at onset of schizophrenia.

Veen ND, Selten JP, van der Tweel I, Feller WG, Hoek HW, Kahn RS.

Am J Psychiatry. 2004 Mar;161(3):501-6.

PMID:
14992976
[PubMed - indexed for MEDLINE]
12.

Clinical characteristics influencing age at onset in psychotic disorders.

Ongür D, Lin L, Cohen BM.

Compr Psychiatry. 2009 Jan-Feb;50(1):13-9. doi: 10.1016/j.comppsych.2008.06.002. Epub 2008 Aug 23.

PMID:
19059508
[PubMed - indexed for MEDLINE]
13.
14.

Impulsivity and sensation seeking in cannabis abusing patients with schizophrenia.

Dervaux A, Goldberger C, Gourion D, Bourdel MC, Laqueille X, Lôo H, Olié JP, Krebs MO.

Schizophr Res. 2010 Nov;123(2-3):278-80. doi: 10.1016/j.schres.2010.08.029. Epub 2010 Sep 15. No abstract available.

PMID:
20832995
[PubMed - indexed for MEDLINE]
15.

Preliminary evidence of an association between childhood abuse and cannabis dependence among African American first-episode schizophrenia-spectrum disorder patients.

Compton MT, Furman AC, Kaslow NJ.

Drug Alcohol Depend. 2004 Dec 7;76(3):311-6.

PMID:
15561482
[PubMed - indexed for MEDLINE]
16.

Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia.

Sevy S, Robinson DG, Napolitano B, Patel RC, Gunduz-Bruce H, Miller R, McCormack J, Lorell BS, Kane J.

Schizophr Res. 2010 Jul;120(1-3):101-7. doi: 10.1016/j.schres.2010.03.037. Epub 2010 May 14.

PMID:
20471224
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Prevalence, correlates and comorbidity of DSM-IV Cannabis Use and Cannabis Use Disorders in Australia.

Teesson M, Slade T, Swift W, Mills K, Memedovic S, Mewton L, Grove R, Newton N, Hall W.

Aust N Z J Psychiatry. 2012 Dec;46(12):1182-92. doi: 10.1177/0004867412460591. Epub 2012 Sep 14.

PMID:
22984111
[PubMed - indexed for MEDLINE]
18.

First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol.

Green AI, Tohen MF, Hamer RM, Strakowski SM, Lieberman JA, Glick I, Clark WS; HGDH Research Group.

Schizophr Res. 2004 Feb 1;66(2-3):125-35.

PMID:
15061244
[PubMed - indexed for MEDLINE]
19.

A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia.

Miller R, Ream G, McCormack J, Gunduz-Bruce H, Sevy S, Robinson D.

Schizophr Res. 2009 Sep;113(2-3):138-44. doi: 10.1016/j.schres.2009.04.018. Epub 2009 May 28.

PMID:
19481424
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

The impact of comorbid cannabis use disorders on the clinical presentation of social anxiety disorder.

Tepe E, Dalrymple K, Zimmerman M.

J Psychiatr Res. 2012 Jan;46(1):50-6. doi: 10.1016/j.jpsychires.2011.09.021. Epub 2011 Nov 1.

PMID:
22047609
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk